-+ 0.00%
-+ 0.00%
-+ 0.00%

EMA'S CHMP: APPLICATION FOR INITIAL MARKETING AUTHORISATION OF BLARCAMESINE ANAVEX WAS WITHDRAWN.

Reuters·03/27/2026 11:42:47

Please log in to view news